TAK-360A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

Sponsor:

Takeda

Code:

NCT07646678

Conditions

Idiopathic Hypersomnia

Narcolepsy Type 1

Narcolepsy Type 2

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TAK-360

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Takeda on 2026-08-21.